The prognostic value of elevated cTnT concentrations and GLS ≥ −15% might not be attributed to background diabetes or CAD as demonstrated by the finding that no substantial change in the HRs of cTnT and a GLS ≥ −15% was found when cTnT and a less negative GLS were added to the model, regardless of whether the model was adjusted for background CAD and diabetes (full model and reduced models 1 and 2 in Table 4). This evidence concerns the gene TNNT2 and diabetes mellitus.